Patients with cirrhosis have an increased risk of short-term mortality, however, few studies quantify the association between neutrophil-to-lymphocyte ratio (NLR) and 90-day transplant-free mortality in cirrhotic patients. We prospectively analyzed 3,970 patients with chronic liver diseases from two multicenter cohorts in China (January 2015 to December 2016 and July 2018 to January 2019). Restricted cubic splines (RCS) were used to analyze the relation of NLR and all-causes 90-day transplant-free mortality in cirrhosis. A total of 2,583 cirrhotic patients were enrolled in our study. Restricted cubic splines showed that the odds ratio (OR) of all causes 90-day transplant-free mortality started to increase rapidly until around NLR 6.5, and then was relatively flat ( for non-linearity <0.001). The risk of 90-day transplant-free mortality in cirrhotic patients with NLR < 6.5 increased with an increment of 23% for every unit increase in NLR ( < 0.001). The patients with NLR < 4.5 had the highest risk (OR: 2.34, 95% CI 1.66-3.28). In multivariable-adjusted stratified analyses, the increase in the incidence of 90-day transplant-free mortality with NLR increasing was consistent (OR >1.0) across all major prespecified subgroups, including infection group (OR: 1.04, 95% CI 1.00-1.09) and non-infection (OR: 1.06, 95% CI 1.02-1.11) group. The trends for NLR and numbers of patients with organ failure varied synchronously and were significantly increased with time from day 7 to day 28. We found a non-linear association between baseline NLR and the adjusted probability of 90-day transplant-free mortality. A certain range of NLR is closely associated with poor short-term prognosis in patients with cirrhosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438214PMC
http://dx.doi.org/10.3389/fmed.2021.726950DOI Listing

Publication Analysis

Top Keywords

90-day transplant-free
20
transplant-free mortality
20
patients cirrhosis
12
neutrophil-to-lymphocyte ratio
8
cirrhotic patients
8
restricted cubic
8
cubic splines
8
patients
7
mortality
6
nlr
6

Similar Publications

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis.

BMC Gastroenterol

November 2024

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.

Background: Decompensated cirrhosis (DC) is prone to recurrent episodes of decompensation following the initial event. This study aimed to identify the risk factors for subsequent decompensation and assess their impact on the outcomes of patients hospitalized for DC.

Methods: Patients with DC were divided into two groups based on the occurrence of new decompensated events during hospitalization.

View Article and Find Full Text PDF

Acute kidney injury (AKI) is one of the common complications of liver cirrhosis. It occurs in nearly 20% of patients with cirrhosis who are hospitalized. Prior literature demonstrated that the AKI occurrence in patients with cirrhosis is independently associated with higher mortality.

View Article and Find Full Text PDF
Article Synopsis
  • Severe alcohol-associated hepatitis (SAH) has a high mortality rate, particularly in patients who don't respond to corticosteroid treatment, with 70%-80% dying within 6 months.
  • A study conducted from January 2016 to November 2023 found that patients treated with granulocyte colony-stimulating factor (G-CSF) showed significantly better 90-day overall survival rates compared to those receiving standard medical therapy or corticosteroids.
  • The G-CSF group also experienced lower rates of gastrointestinal bleeding and better long-term survival without the need for a transplant, highlighting its potential as a treatment option for SAH.
View Article and Find Full Text PDF

aCCI-HBV-ACLF: A Novel Predictive Model for Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.

Aliment Pharmacol Ther

January 2025

State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, China.

Background: Early identification of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) holds crucial importance in guiding clinical management and reducing mortality. However, existing scoring systems often overlook patient's underlying clinical condition, which significantly impacts prognosis.

Aims: Use the age-adjusted Charlson comorbidity index (aCCI) to evaluate the patient's complications to develop a more precise model for predicting transplant-free mortality in HBV-ACLF patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on finding predictive factors and developing prognostic models for acute-on-chronic liver disease (AoCLD) caused by hepatitis B virus and alcohol consumption.
  • Two nomograms, CATCH-LIFE A and CATCH-LIFE B, were created using data from two cohorts, showing strong abilities to predict 28-day and 90-day mortality rates.
  • These nomograms can help in identifying high- and low-risk patients, potentially improving treatment strategies and survival outcomes for AoCLD patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!